These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 18487913

  • 1. [Safety and efficacy analysis of FOLFOX4 regimen in elderly compared to younger colorectal cancer patients].
    Kuboki Y, Ichimura T, Ogura M, Matsuda M, Suenaga M, Shinozaki E, Matsuzaka S, Chin K, Mizunuma N, Hatake K.
    Gan To Kagaku Ryoho; 2008 May; 35(5):781-5. PubMed ID: 18487913
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H, Tsuboi K, Honda I, Kato N, Okochi O, Kobayashi D, Hattori M.
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [Abstract] [Full Text] [Related]

  • 3. FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study.
    Berretta M, Cappellani A, Fiorica F, Nasti G, Frustaci S, Fisichella R, Bearz A, Talamini R, Lleshi A, Tambaro R, Cocciolo A, Ristagno M, Bolognese A, Basile F, Meneguzzo N, Berretta S, Tirelli U.
    Arch Gerontol Geriatr; 2011 May; 52(1):89-93. PubMed ID: 20211502
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy and safety of modified FOLFOX6 regimen in aged patients with nonresectable colorectal cancer].
    Ishiguro T, Ishibashi K, Okada N, Kuwabara K, Miyazaki T, Yokoyama M, Matsuki M, Sano M, Inoue N, Ishida H.
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2286-8. PubMed ID: 19106598
    [Abstract] [Full Text] [Related]

  • 5. FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
    Figer A, Perez-Staub N, Carola E, Tournigand C, Lledo G, Flesch M, Barcelo R, Cervantes A, André T, Colin P, Louvet C, de Gramont A.
    Cancer; 2007 Dec 15; 110(12):2666-71. PubMed ID: 17963264
    [Abstract] [Full Text] [Related]

  • 6. Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.
    Fuse N, Doi T, Ohtsu A, Takeuchi S, Kojima T, Taku K, Tahara M, Muto M, Asaka M, Yoshida S.
    Jpn J Clin Oncol; 2007 Jun 15; 37(6):434-9. PubMed ID: 17656481
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
    Matsumoto S, Nishimura T, Kanai M, Mori Y, Nagayama S, Kawamura J, Nomura A, Miyamoto S, Kitano T, Ishiguro H, Yanagihara K, Teramukai S, Sakai Y, Chiba T, Fukushima M.
    Chemotherapy; 2008 Jun 15; 54(5):395-403. PubMed ID: 18781065
    [Abstract] [Full Text] [Related]

  • 8. [Revision of the informed consent form for patients based on investigation of adverse events of mFOLFOX6 regimen].
    Kato T, Matsunaga Y, Motokawa S, Nakagaki S, Nagata N, Yoshida T, Muramatsu T, Kimura H, Ohashi Y, Kudou Y, Shino M, Yamazaki K, Boku N.
    Gan To Kagaku Ryoho; 2009 Oct 15; 36(10):1697-702. PubMed ID: 19838030
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy of m-FOLFOX6 therapy for colorectal cancer in elderly patients].
    Young Kim W, Maeda K, Noda E, Fukunaga S, Inoue T, Kaizaki R, Shinto O, Wada K, Nakano T, Hirakawa K.
    Gan To Kagaku Ryoho; 2007 Nov 15; 34(11):1833-6. PubMed ID: 18030018
    [Abstract] [Full Text] [Related]

  • 10. [PSK decreased FOLFOX4-induced peripheral neuropathy and bone marrow suppression in patients with metastatic colorectal cancer].
    Shibata M, Shimura T, Nishina Y, Gonda K, Matsuo S, Abe H, Yajima Y, Nakamura I, Ohki S, Takenoshita S.
    Gan To Kagaku Ryoho; 2011 May 15; 38(5):797-801. PubMed ID: 21566440
    [Abstract] [Full Text] [Related]

  • 11. [Clinical study of irinotecan plus infusional fluorouracil/l-leucovorin (FOLFIRI) in patients with fluoropyrimidine-resistant metastatic colorectal cancer].
    Moriwaki T, Hyodo I, Nishina T, Kajiwara T, Kataoka J, Hori S, Nasu J, Imamine S, Iguchi H.
    Gan To Kagaku Ryoho; 2007 Dec 15; 34(13):2249-53. PubMed ID: 18079624
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.
    Kandutsch S, Klinger M, Hacker S, Wrba F, Gruenberger B, Gruenberger T.
    Eur J Surg Oncol; 2008 Nov 15; 34(11):1231-6. PubMed ID: 18272318
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of withdrawal of 5-fluorouracil bolus administration on recovery from neutropenia in colorectal cancer patients treated with mFOLFOX6 chemotherapy-comparison with total dosage reduction].
    Ueda H, Demizu M, Oosawa M, Chihara S, Nakanishi Y, Maeda C, Yano K, Kimura F, Iwakawa S.
    Gan To Kagaku Ryoho; 2009 May 15; 36(5):789-93. PubMed ID: 19461179
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Retrospective analysis of FOLFOX4 neurotoxicity for recovery from advanced colorectal cancer].
    Matsuda M, Matsusaka S, Kuboki Y, Itimura T, Ogura M, Suenaga M, Syouji D, Watanabe C, Chin K, Mizunuma N, Hatake K.
    Gan To Kagaku Ryoho; 2008 Mar 15; 35(3):461-6. PubMed ID: 18347395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.